AQST logo

Aquestive Therapeutics (AQST) Cash From Investing

Annual CFI

-$995.00 K
+$1.53 M+60.58%

December 31, 2023

Summary

Performance

1-Year Change

+60.58%

3-Year Change

-92.46%

5-Year Change

+45.45%

15-Year Change

+51.89%

AQST Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.88%
AQST annual cash flow from investing activities is higher than 43.88% of companies in Healthcare sector

High & Low

All-time High

$190.00 K
AQST annual cash flow from investing activities is currently -623.68% below its historical high of $190.00 thousand

3-Year Low

-$2.52 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AQST previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
AQST next annual earnings announcement is scheduled for Mar 5, 2025

OtherAQSTcash flowmetrics:

Annual CFF

$3.97 M
AQST annual cash flow from financing activities is $3.97 million

Annual CFO

-$6.38 M
AQST annual cash flow from operations is -$6.38 million

Annual FCF

-$7.38 M
AQST annual free cash flow is -$7.38 million

Annual CAPEX

$995.00 K
AQST annual capital expenditures is $995.00 thousand

Quarterly CFI

-$80.00 K
-$45.00 K-128.57%

September 30, 2024

Summary

Performance

3-Month Change

-128.57%

1-Year Change

+47.02%

3-Year Change

+47.02%

5-Year Change

+47.02%

AQST Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.19%
AQST quarterly cash flow from investing activities is higher than 44.19% of companies in Healthcare sector

High & Low

All-time High

-$2000.00

3-Year Low

-$1.72 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AQST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
AQST next earnings announcement is scheduled for Mar 5, 2025

OtherAQSTcash flowmetrics:

Quarterly CFF

-$17.00 K
AQST quarterly cash flow from financing activities is -$17.00 thousand

Quarterly CFO

-$11.88 M
AQST quarterly cash flow from operations is -$11.88 million

Quarterly FCF

-$11.96 M
AQST quarterly free cash flow is -$11.96 million

Quarterly CAPEX

$80.00 K
AQST quarterly capital expenditures is $80.00 thousand

TTM CFI

-$160.00 K
+$71.00 K+30.74%

September 30, 2024

Summary

Performance

3-Month Change

+30.74%

1-Year Change

+84.08%

3-Year Change

+84.08%

5-Year Change

+84.08%

AQST TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.98%
AQST TTM cash flow from investing activities is higher than 53.98% of companies in Healthcare sector

High & Low

All-time High

-$160.00 K
AQST TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$3.03 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AQST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
AQST next earnings announcement is scheduled for Mar 5, 2025

OtherAQSTcash flowmetrics:

TTM CFF

$87.35 M
AQST TTM cash flow from financing activities is $87.35 million

TTM CFO

-$34.21 M
AQST TTM cash flow from operations is -$34.21 million

TTM FCF

-$34.37 M
AQST TTM free cash flow is -$34.37 million

TTM CAPEX

$160.00 K
AQST TTM capital expenditures is $160.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AQST Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+60.6%+47.0%+84.1%
3 y3 years-92.5%+47.0%+84.1%
5 y5 years+45.5%+47.0%+84.1%

AQST Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.0%+60.6%-3900.0%+95.3%at high+94.7%
5 y5-year-92.5%+60.6%-3900.0%+95.3%at high+94.7%
alltimeall time-623.7%+60.6%-3900.0%+95.3%at high+94.7%

Aquestive Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$80.00 K(+128.6%)
-$160.00 K(-30.7%)
Jun 2024
-
-$35.00 K(+20.7%)
-$231.00 K(-77.4%)
Mar 2024
-
-$29.00 K(+81.3%)
-$1.02 M(+2.7%)
Dec 2023
-$995.00 K(-60.6%)
-$16.00 K(-89.4%)
-$995.00 K(-1.0%)
Sep 2023
-
-$151.00 K(-81.7%)
-$1.00 M(-60.9%)
Jun 2023
-
-$826.00 K(>+9900.0%)
-$2.57 M(+6.2%)
Mar 2023
-
-$2000.00(-92.3%)
-$2.42 M(-4.0%)
Dec 2022
-$2.52 M(+176.5%)
-$26.00 K(-98.5%)
-$2.52 M(-16.7%)
Sep 2022
-
-$1.72 M(+153.6%)
-$3.03 M(+117.0%)
Jun 2022
-
-$677.00 K(+551.0%)
-$1.40 M(+52.8%)
Mar 2022
-
-$104.00 K(-80.5%)
-$914.00 K(+0.1%)
Dec 2021
-$913.00 K(+76.6%)
-$533.00 K(+542.2%)
-$913.00 K(+48.2%)
Sep 2021
-
-$83.00 K(-57.2%)
-$616.00 K(+7.9%)
Jun 2021
-
-$194.00 K(+88.3%)
-$571.00 K(+16.8%)
Mar 2021
-
-$103.00 K(-56.4%)
-$489.00 K(-5.4%)
Dec 2020
-$517.00 K
-$236.00 K(+521.1%)
-$517.00 K(+40.9%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$38.00 K(-66.1%)
-$367.00 K(-12.6%)
Jun 2020
-
-$112.00 K(-14.5%)
-$420.00 K(+0.5%)
Mar 2020
-
-$131.00 K(+52.3%)
-$418.00 K(-37.0%)
Dec 2019
-$663.00 K(-63.7%)
-$86.00 K(-5.5%)
-$663.00 K(-37.9%)
Sep 2019
-
-$91.00 K(-17.3%)
-$1.07 M(-25.1%)
Jun 2019
-
-$110.00 K(-70.7%)
-$1.42 M(-26.6%)
Mar 2019
-
-$376.00 K(-23.3%)
-$1.94 M(+6.4%)
Dec 2018
-$1.82 M(-11.8%)
-$490.00 K(+9.4%)
-$1.82 M(+28.3%)
Sep 2018
-
-$448.00 K(-28.5%)
-$1.42 M(+1.1%)
Jun 2018
-
-$627.00 K(+142.1%)
-$1.41 M(-15.7%)
Mar 2018
-
-$259.00 K(+194.3%)
-$1.67 M(-19.2%)
Dec 2017
-$2.07 M(-1188.4%)
-$88.00 K(-79.7%)
-$2.07 M(+4.4%)
Sep 2017
-
-$433.00 K(-51.3%)
-$1.98 M(+28.0%)
Jun 2017
-
-$890.00 K(+35.5%)
-$1.55 M(+135.5%)
Mar 2017
-
-$657.00 K
-$657.00 K
Dec 2016
$190.00 K
-
-

FAQ

  • What is Aquestive Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Aquestive Therapeutics?
  • What is Aquestive Therapeutics annual CFI year-on-year change?
  • What is Aquestive Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Aquestive Therapeutics?
  • What is Aquestive Therapeutics quarterly CFI year-on-year change?
  • What is Aquestive Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Aquestive Therapeutics?
  • What is Aquestive Therapeutics TTM CFI year-on-year change?

What is Aquestive Therapeutics annual cash flow from investing activities?

The current annual CFI of AQST is -$995.00 K

What is the all time high annual CFI for Aquestive Therapeutics?

Aquestive Therapeutics all-time high annual cash flow from investing activities is $190.00 K

What is Aquestive Therapeutics annual CFI year-on-year change?

Over the past year, AQST annual cash flow from investing activities has changed by +$1.53 M (+60.58%)

What is Aquestive Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of AQST is -$80.00 K

What is the all time high quarterly CFI for Aquestive Therapeutics?

Aquestive Therapeutics all-time high quarterly cash flow from investing activities is -$2000.00

What is Aquestive Therapeutics quarterly CFI year-on-year change?

Over the past year, AQST quarterly cash flow from investing activities has changed by +$71.00 K (+47.02%)

What is Aquestive Therapeutics TTM cash flow from investing activities?

The current TTM CFI of AQST is -$160.00 K

What is the all time high TTM CFI for Aquestive Therapeutics?

Aquestive Therapeutics all-time high TTM cash flow from investing activities is -$160.00 K

What is Aquestive Therapeutics TTM CFI year-on-year change?

Over the past year, AQST TTM cash flow from investing activities has changed by +$845.00 K (+84.08%)